PLx Pharma Winddown Corp.

2020 Q3 Form 10-Q Financial Statement

#000143774920023827 Filed on November 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3 2019 Q2

Balance Sheet

Concept 2020 Q3 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.090M $18.51M $21.26M
YoY Change -50.89% 11.91% 18.64%
Cash & Equivalents $9.087M $18.51M $21.26M
Short-Term Investments
Other Short-Term Assets $390.0K $250.0K $270.0K
YoY Change 56.0% -55.36% -76.72%
Inventory $143.4K $0.00 $0.00
Prepaid Expenses
Receivables $0.00 $0.00 $190.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $9.618M $18.76M $21.72M
YoY Change -48.73% 9.45% 13.01%
LONG-TERM ASSETS
Property, Plant & Equipment $1.252M $1.392M $1.364M
YoY Change -10.04% -3.98% -10.05%
Goodwill $2.061M $2.061M $2.061M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $20.00K $70.00K $70.00K
YoY Change -71.43% 0.0% 0.0%
Total Long-Term Assets $3.733M $4.227M $4.068M
YoY Change -11.68% 18.11% 11.59%
TOTAL ASSETS
Total Short-Term Assets $9.618M $18.76M $21.72M
Total Long-Term Assets $3.733M $4.227M $4.068M
Total Assets $13.35M $22.99M $25.78M
YoY Change -41.92% 10.95% 12.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $610.0K $1.290M $1.500M
YoY Change -52.71% 72.0% 212.5%
Accrued Expenses $1.620M $1.260M $1.060M
YoY Change 28.57% 50.0% 70.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.549M $3.626M $3.594M
YoY Change -57.29% 85.74% 258.31%
Total Short-Term Liabilities $3.811M $6.174M $6.155M
YoY Change -38.27% 74.36% 192.92%
LONG-TERM LIABILITIES
Long-Term Debt $1.549M $2.467M
YoY Change -70.07% -59.3%
Other Long-Term Liabilities $146.4K $488.6K $378.0K
YoY Change -70.03% 292.86% 190.18%
Total Long-Term Liabilities $146.4K $2.037M $2.845M
YoY Change -92.81% -61.55% -54.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.811M $6.174M $6.155M
Total Long-Term Liabilities $146.4K $2.037M $2.845M
Total Liabilities $11.69M $19.53M $25.46M
YoY Change -40.17% 12.79% 56.14%
SHAREHOLDERS EQUITY
Retained Earnings -$94.17M -$84.94M -$86.64M
YoY Change 10.87% 22.42% 31.36%
Common Stock $74.45M $74.73M $73.30M
YoY Change -0.38% 2.68% 1.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$19.72M -$10.21M -$13.34M
YoY Change
Total Liabilities & Shareholders Equity $13.35M $22.99M $25.78M
YoY Change -41.92% 10.95% 12.78%

Cashflow Statement

Concept 2020 Q3 2019 Q3 2019 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 plxp Accrued Bonuses And Severances Current
AccruedBonusesAndSeverancesCurrent
718092
CY2019Q4 plxp Accrued Bonuses And Severances Current
AccruedBonusesAndSeverancesCurrent
1166821
CY2019Q1 plxp Adjustments To Additional Paid In Capital Preferred Stock Beneficial Conversion Feature At Issuance
AdjustmentsToAdditionalPaidInCapitalPreferredStockBeneficialConversionFeatureAtIssuance
12692308
CY2019Q1 plxp Adjustments To Additional Paid In Capital Preferred Stock Beneficial Conversion Feature Deemed Dividend
AdjustmentsToAdditionalPaidInCapitalPreferredStockBeneficialConversionFeatureDeemedDividend
-12692308
plxp Beneficial Conversion Feature And Dividends Of Preferred Stock
BeneficialConversionFeatureAndDividendsOfPreferredStock
1227422
plxp Beneficial Conversion Feature And Dividends Of Preferred Stock
BeneficialConversionFeatureAndDividendsOfPreferredStock
13433397
CY2020Q3 plxp Dividends Payable Noncurrent
DividendsPayableNoncurrent
2285920
CY2019Q4 plxp Dividends Payable Noncurrent
DividendsPayableNoncurrent
1058498
plxp Increase Decrease In Bonuses And Severances
IncreaseDecreaseInBonusesAndSeverances
-448729
plxp Increase Decrease In Bonuses And Severances
IncreaseDecreaseInBonusesAndSeverances
-141263
plxp Increase Decrease In Interest Payable Net Excluding Related Parties
IncreaseDecreaseInInterestPayableNetExcludingRelatedParties
53050
plxp Increase Decrease In Interest Payable Net Excluding Related Parties
IncreaseDecreaseInInterestPayableNetExcludingRelatedParties
133410
plxp Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-215518
plxp Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-12538
CY2020Q3 plxp Interest Payable Noncurrent
InterestPayableNoncurrent
CY2019Q4 plxp Interest Payable Noncurrent
InterestPayableNoncurrent
501826
CY2020Q3 plxp Net Income Loss Available To Common Stockholders Before Impact Of Preferred Stock Participation Rights
NetIncomeLossAvailableToCommonStockholdersBeforeImpactOfPreferredStockParticipationRights
-3626289
CY2019Q3 plxp Net Income Loss Available To Common Stockholders Before Impact Of Preferred Stock Participation Rights
NetIncomeLossAvailableToCommonStockholdersBeforeImpactOfPreferredStockParticipationRights
1392586
plxp Net Income Loss Available To Common Stockholders Before Impact Of Preferred Stock Participation Rights
NetIncomeLossAvailableToCommonStockholdersBeforeImpactOfPreferredStockParticipationRights
-8456792
plxp Net Income Loss Available To Common Stockholders Before Impact Of Preferred Stock Participation Rights
NetIncomeLossAvailableToCommonStockholdersBeforeImpactOfPreferredStockParticipationRights
-31935722
plxp Proceeds From Issuance Of Common Stock Net Issuance Costs
ProceedsFromIssuanceOfCommonStockNetIssuanceCosts
plxp Proceeds From Issuance Of Common Stock Net Issuance Costs
ProceedsFromIssuanceOfCommonStockNetIssuanceCosts
1941987
CY2020Q3 plxp Temporary Equity Value Stock Issuance Cost
TemporaryEquityValueStockIssuanceCost
CY2020Q3 plxp Working Capital
WorkingCapital
5800000
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
612367
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
928921
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
74437924
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
74837046
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
162942
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
301735
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
311136
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
272537
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
269578
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
286185
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
66232
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
276505
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
260577
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
80979
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
172438
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13957604
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10306370
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13957604
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10503537
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020Q3 us-gaap Assets
Assets
13350837
CY2019Q4 us-gaap Assets
Assets
18502746
CY2020Q3 us-gaap Assets Current
AssetsCurrent
9617706
CY2019Q4 us-gaap Assets Current
AssetsCurrent
14283255
CY2020Q3 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
0
CY2019Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
0
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2847
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9086525
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14001304
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9100000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14001304
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14250267
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9086525
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18509487
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4914779
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4259220
CY2020Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
9100000
CY2017Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.50
CY2017Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2646091
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9156260
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9156260
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9156260
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9156260
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
9156
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
9156
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
143380
CY2019Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
CY2020Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
17035
CY2019Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
73665
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
98062
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
126692
CY2020Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
5442717
CY2019Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
8247679
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.92
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.60
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.92
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.60
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y292D
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1900000
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-134552
CY2019Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5498391
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2804962
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
7581521
CY2020Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-218150
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-12398
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1981037
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2503314
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6681452
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7180674
CY2020Q3 us-gaap Goodwill
Goodwill
2061022
CY2019Q4 us-gaap Goodwill
Goodwill
2061022
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3126492
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1703722
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7229370
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18502325
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-316554
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
820711
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18683
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18234
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
143380
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-225435
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-25912
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
67903
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-165618
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
14910
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
72705
CY2019Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
118432
us-gaap Interest Expense Debt
InterestExpenseDebt
267213
us-gaap Interest Expense Debt
InterestExpenseDebt
476084
us-gaap Interest Paid Net
InterestPaidNet
189948
us-gaap Interest Paid Net
InterestPaidNet
486902
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
589840
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
34964
CY2020Q3 us-gaap Inventory Net
InventoryNet
143400
CY2019Q4 us-gaap Inventory Net
InventoryNet
0
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
59000
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
513000
us-gaap Lease Cost
LeaseCost
80323
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
503401
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
262850
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
30132
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
60264
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
60819
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
89336
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
49010
CY2020Q3 us-gaap Liabilities
Liabilities
11686400
CY2019Q4 us-gaap Liabilities
Liabilities
16933129
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13350837
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18502746
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3811339
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6093430
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1548865
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3658121
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
622265
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4910812
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13416065
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-102000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-134219
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9723591
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9022626
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
1703722
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-3126492
us-gaap Net Income Loss
NetIncomeLoss
-7229370
us-gaap Net Income Loss
NetIncomeLoss
-18502325
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1496086
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-5598964
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-10858751
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-9347296
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
837078
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
837078
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
61847
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5379959
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2537749
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8057605
CY2020Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
3188339
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
3717343
us-gaap Operating Expenses
OperatingExpenses
9797549
us-gaap Operating Expenses
OperatingExpenses
10986291
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3188339
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3676237
us-gaap Operating Income Loss
OperatingIncomeLoss
-9767119
us-gaap Operating Income Loss
OperatingIncomeLoss
-10444720
us-gaap Operating Lease Cost
OperatingLeaseCost
263054
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
87851
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
105072
us-gaap Operating Lease Expense
OperatingLeaseExpense
263054
us-gaap Operating Lease Expense
OperatingLeaseExpense
289553
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
454391
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
402640
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
618158
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.095
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
342175
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
304603
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
146424
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
409431
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
102000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
145661
CY2020Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
499797
CY2019Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
311136
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
1227422
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
13433397
CY2019Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
311136
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
930000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
930000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
387801
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
263268
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
11442
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1252434
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1466646
CY2020Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
CY2019Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
18683
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2812500
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2187500
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1207302
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1214029
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3116097
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3805617
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
30430
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-94167533
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86938163
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
41106
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
541571
us-gaap Share Based Compensation
ShareBasedCompensation
828300
us-gaap Share Based Compensation
ShareBasedCompensation
603314
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1116314
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
17.49
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
198750
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.52
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
571000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
91475
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
528580
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1666797
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2039047
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.96
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.29
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.19
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y219D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y80D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y54D
us-gaap Stock Issued1
StockIssued1
us-gaap Stock Issued1
StockIssued1
45000
CY2019Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
22500
CY2019Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
22500
CY2019Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
462902
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1479085
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-19720453
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-12091961
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-10643628
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-16380349
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
6444293
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-4453944
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-13341068
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-10208820
us-gaap Sublease Income
SubleaseIncome
182731
CY2019Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
555508
CY2020Q2 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
CY2019Q1 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but <div style="display: inline; font-style: italic; font: inherit;">not</div> limited to, determining the fair value of warrant liabilities and other financial instruments, stock-based compensation, contingent liabilities, the fair value and depreciable lives of long-lived tangible and intangible assets, and deferred taxes and the associated valuation allowance. Actual results could differ from those estimates.</div></div></div>
CY2017Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P10Y
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8936255
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9156260
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9156260
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8860168
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8921345
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9156260
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9156260
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8860168

Files In Submission

Name View Source Status
0001437749-20-023827-index-headers.html Edgar Link pending
0001437749-20-023827-index.html Edgar Link pending
0001437749-20-023827.txt Edgar Link pending
0001437749-20-023827-xbrl.zip Edgar Link pending
ex_210634.htm Edgar Link pending
ex_210635.htm Edgar Link pending
ex_210636.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
plxp-20200930.xml Edgar Link completed
plxp-20200930.xsd Edgar Link pending
plxp-20200930_cal.xml Edgar Link unprocessable
plxp-20200930_def.xml Edgar Link unprocessable
plxp-20200930_lab.xml Edgar Link unprocessable
plxp-20200930_pre.xml Edgar Link unprocessable
plxp20200930_10q.htm Edgar Link pending
plxp20200930_10qimg001.jpg Edgar Link pending
plxp20200930_10qimg002.gif Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending